327 related articles for article (PubMed ID: 14745804)
1. Amyloidosis of Alzheimer's Abeta peptides: solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies.
Antzutkin ON
Magn Reson Chem; 2004 Feb; 42(2):231-46. PubMed ID: 14745804
[TBL] [Abstract][Full Text] [Related]
2. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
Jun S; Gillespie JR; Shin BK; Saxena S
Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
[TBL] [Abstract][Full Text] [Related]
3. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR.
Sharpe S; Yau WM; Tycko R
Protein Expr Purif; 2005 Jul; 42(1):200-10. PubMed ID: 15939307
[TBL] [Abstract][Full Text] [Related]
4. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
[TBL] [Abstract][Full Text] [Related]
5. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
6. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
Karr JW; Szalai VA
Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
[TBL] [Abstract][Full Text] [Related]
7. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
[TBL] [Abstract][Full Text] [Related]
8. N-Terminal deletions modify the Cu2+ binding site in amyloid-beta.
Karr JW; Akintoye H; Kaupp LJ; Szalai VA
Biochemistry; 2005 Apr; 44(14):5478-87. PubMed ID: 15807541
[TBL] [Abstract][Full Text] [Related]
9. Capturing intermediate structures of Alzheimer's beta-amyloid, Abeta(1-40), by solid-state NMR spectroscopy.
Chimon S; Ishii Y
J Am Chem Soc; 2005 Oct; 127(39):13472-3. PubMed ID: 16190691
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.
Karr JW; Kaupp LJ; Szalai VA
J Am Chem Soc; 2004 Oct; 126(41):13534-8. PubMed ID: 15479110
[TBL] [Abstract][Full Text] [Related]
12. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
Benseny-Cases N; Cócera M; Cladera J
Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
[TBL] [Abstract][Full Text] [Related]
13. Review: model peptides and the physicochemical approach to beta-amyloids.
Lynn DG; Meredith SC
J Struct Biol; 2000 Jun; 130(2-3):153-73. PubMed ID: 10940223
[TBL] [Abstract][Full Text] [Related]
14. The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.
Murakami K; Masuda Y; Shirasawa T; Shimizu T; Irie K
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S169-79. PubMed ID: 20590832
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
16. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of a soluble amyloid beta-peptide oligomer.
Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
[TBL] [Abstract][Full Text] [Related]
18. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+.
Olofsson A; Lindhagen-Persson M; Vestling M; Sauer-Eriksson AE; Ohman A
FEBS J; 2009 Aug; 276(15):4051-60. PubMed ID: 19549187
[TBL] [Abstract][Full Text] [Related]
19. AFM and STM study of beta-amyloid aggregation on graphite.
Wang Z; Zhou C; Wang C; Wan L; Fang X; Bai C
Ultramicroscopy; 2003; 97(1-4):73-9. PubMed ID: 12801659
[TBL] [Abstract][Full Text] [Related]
20. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.
Huang TH; Yang DS; Plaskos NP; Go S; Yip CM; Fraser PE; Chakrabartty A
J Mol Biol; 2000 Mar; 297(1):73-87. PubMed ID: 10704308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
